BioLife Sciences Inc. (BLFE)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 259.16 Thousand USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 42.28 Thousand USD | -87.15% |
| 2017 | 329.13 Thousand USD | 2533.05% |
| 2016 | 12.5 Thousand USD | -40.91% |
| 2015 | 21.15 Thousand USD | 0.0% |
| 2007 | 1.52 Million USD | 37.01% |
| 2006 | 1.11 Million USD | 109.18% |
| 2005 | 532.7 Thousand USD | 2498.57% |
| 2004 | 20.5 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | 122.80 USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 126.22 Thousand USD | 120.3% |
| 2021 Q1 | 57.29 Thousand USD | 0.0% |
| 2021 Q3 | 134.75 Thousand USD | 6.76% |
| 2020 FY | 259.16 Thousand USD | 0.0% |
| 2019 FY | - USD | -100.0% |
| 2018 FY | 42.28 Thousand USD | -87.15% |
| 2017 FY | 329.13 Thousand USD | 2533.05% |
| 2016 FY | 12.5 Thousand USD | -40.91% |
| 2015 FY | 21.15 Thousand USD | 0.0% |
| 2008 Q2 | 272.01 Thousand USD | 19.01% |
| 2008 Q1 | 228.56 Thousand USD | -53.51% |
| 2007 Q2 | 362.2 Thousand USD | 65.61% |
| 2007 Q4 | 491.69 Thousand USD | 45.57% |
| 2007 Q1 | 218.71 Thousand USD | -16.92% |
| 2007 FY | 1.52 Million USD | 37.01% |
| 2007 Q3 | 337.76 Thousand USD | -6.75% |
| 2006 Q2 | 2624.00 USD | -99.69% |
| 2006 FY | 1.11 Million USD | 109.18% |
| 2006 Q4 | 263.24 Thousand USD | -37.48% |
| 2006 Q1 | 837.3 Thousand USD | 100.51% |
| 2006 Q3 | 421.07 Thousand USD | 15947.14% |
| 2005 Q1 | 3500.00 USD | 0.0% |
| 2005 Q2 | -35.5 Thousand USD | -1114.29% |
| 2005 Q3 | 76.12 Thousand USD | 314.43% |
| 2005 FY | 532.7 Thousand USD | 2498.57% |
| 2005 Q4 | 417.58 Thousand USD | 448.58% |
| 2004 FY | 20.5 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 100.0% |
| Ansell Limited | 495.5 Million USD | 100.0% |
| Ansell Limited | 495.5 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 82.8 Million USD | 100.0% |
| CB Scientific, Inc. | 1.73 Million USD | 100.0% |
| Psykey, Inc. | 1.21 Million USD | 100.0% |
| ConvaTec Group Plc | 910.31 Million USD | 100.0% |
| ConvaTec Group Plc | 872.5 Million USD | 100.0% |
| Encision Inc. | 3.77 Million USD | 100.0% |
| Golden Valley Development, Inc | 141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | 6.09 Million USD | 100.0% |
| LifePoint, Inc. | 7.42 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 726.13 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 1.06 Million USD | 100.0% |
| SmileDirectClub, Inc. | 517 Million USD | 100.0% |
| Sector 10, Inc. | 39.84 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 100.0% |
| SheerVision, Inc. | 2.33 Million USD | 100.0% |
| United Health Products, Inc. | 2.42 Million USD | 100.0% |
| Vasamed, Inc. | 4.67 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 100.0% |
| Yubo International Biotech Limited | 1.25 Million USD | 100.0% |